Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes
Completed
Conditions studied: Femoral Arteriotomy Closure
In brief
This is an observational study designed to evaluate the safety and clinical outcomes of the MANTA® Vascular Closure Device (VCD) (the MANTA® Device) in TAVR procedures. The study will enroll participants who are undergoing a TAVR procedure. The purpose of this study is to examine and collect data on outcomes of contemporary MANTA® large bore closure in standard of care (SOC) TAVR procedures with on-label use of the MANTA® device including appropriate patient selection and proper vascular access.
Key facts
- Study ID
- NCT05936996
- Run by
- Essential Medical, Inc.
- People needed
- 258
- Starts
- 2023-11-15
- Expected to finish
- 2025-10-30
- Last updated by the study team
- 2025-11-12
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Candidate meets criteria for on-label use of MANTA® VCD as specified in the country-specific MANTA® VCD Instructions for Use (IFU), per judgement of the investigator.
- Age ≥21 years
You may not qualify if…
- Unable or unwilling to give informed consent or unwilling to complete follow-up assessments.
Where it is running
- Baptist Health Medical Center-Jacksonville — Jacksonville, Florida, United States
- Orlando Health, Inc — Orlando, Florida, United States
- Henry Ford Health — Detroit, Michigan, United States
- University at Buffalo — Buffalo, New York, United States
- North Shore University Hospital — Manhasset, New York, United States
- Mount Sinai Hospital — New York, New York, United States
- Montefiore Medical Center — New York, New York, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- Baylor Scott & White - Round Rock — Round Rock, Texas, United States
- Montreal Heart Institute — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.